EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Evaluation of Inflammatory Biomarkers in Cervical Cancer Treated with Chemoradiotherapy

Timur Koca, Nurcihan Gocen Vardar, Rahmi Atıl Aksoy iD, Aylin Fidan Korcum

Current Oncology · 2025

DOI: 10.3390/curroncol32010039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Timur Koca und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Akdeniz University, 07070 Antalya, Turkey. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Chemoradiotherapy, Biomarkers, Tumor, Inflammation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Inflammatory biomarkers have been shown to possess both prognostic and predictive significance in various cancers. Among the emerging biomarkers, the pan-immune-inflammation value (PIV) has recently been introduced as a novel indicator representing both the immune response and the systemic inflammatory state. This study aims to comprehensively evaluate the predictive value of inflammatory biomarkers on survival outcomes in cervical cancer patients undergoing chemoradiotherapy.

Methods

A total of 90 patients who had undergone chemoradiotherapy for cervical cancer were included. Data on demographics, treatment protocols, pre-treatment blood parameters, and survival outcomes were collected. The association between inflammatory biomarkers and survival outcomes was investigated through univariate and multivariate analyses.

Results

The univariate analysis identified the following as predictors of progression-free survival (PFS): neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), monocyte–lymphocyte ratio (MLR), systemic immune-inflammation index (SII), PIV, C-reactive protein (CRP), albumin, and tumor size. Multivariate analysis revealed that only the PIV significantly predicted PFS (HR 3.05, 95% CI 1.0 to 9.3, p = 0.04). In the univariate analysis, several variables were predictive of overall survival (OS), including NLR, PLR, MLR, SII, PIV, CRP, LDH, albumin, tumor size, and Eastern Cooperative Oncology Group Performance Status (ECOG PS). Multivariate analysis revealed CRP (HR 3.41, 95% CI 1.5 to 7.7, p = 0.003) and ECOG PS (HR 4.78, 95% CI 1.3 to 17.3, p = 0.01) predictive of OS, with PIV approaching statistical significance (HR 2.56, 95% CI 0.8 to 7.6, p = 0.09).

Conclusions

This study provides the first comprehensive analysis of the association between cervical cancer and various inflammatory biomarkers. Many of these biomarkers have demonstrated predictive value for survival outcomes in patients with cervical cancer undergoing definitive chemoradiotherapy. Among the biomarkers evaluated, CRP and PIV were identified as the most predictive, warranting further exploration in future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsChemoradiotherapyBiomarkers, TumorInflammationHumansFemaleMiddle AgedAdultAgedPrognosis

Stichwörter der Autor:innen

biomarkerscervical cancerchemotherapyinflammationradiotherapysurvival

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Radiation Oncology, Akdeniz University, 07070 Antalya, Turkey.
  • Department of Radiation Oncology, Izmir City Hospital, 35540 Izmir, Turkey.

ORCID-Profile: Rahmi Atıl Aksoy

Zitieren

APA

Koca, T., Gocen Vardar, N., Aksoy, R. A., & Korcum, A. F. (2025). Comprehensive Evaluation of Inflammatory Biomarkers in Cervical Cancer Treated with Chemoradiotherapy. Current Oncology. https://doi.org/10.3390/curroncol32010039

Vancouver

Koca T, Gocen Vardar N, Aksoy RA, Korcum AF. Comprehensive Evaluation of Inflammatory Biomarkers in Cervical Cancer Treated with Chemoradiotherapy. Current Oncology. 2025. doi:10.3390/curroncol32010039

BibTeX
@article{Koca2025,
  author = {Koca, Timur and Gocen Vardar, Nurcihan and Aksoy, Rahmi Atıl and Korcum, Aylin Fidan},
  title = {Comprehensive Evaluation of Inflammatory Biomarkers in Cervical Cancer Treated with Chemoradiotherapy},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32010039}
}
Kostenlos starten →